ArticlePloS one2014

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.

Nicholas J Izzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.